OMER
Omeros Corporation
NASDAQ: OMER · HEALTHCARE · BIOTECHNOLOGY
$14.60
+0.27% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
4.43x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$3 – $18
Volume
1.1M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
5.0
Growth
C+5.0
Quality
C+3.0
Profitability
D6.0
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$38.00
+160.27%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 14.90% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-39.84M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $-30.00M |
| Net income | $47.42M | $-117.81M | $-156.81M | $-3.35M | $86.45M |
| EPS | — | — | — | — | $-0.08 |
| Free cash flow | $-86.60M | $74.30M | $-148.97M | $-116.16M | $-39.84M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Omeros Corporation trades at $14.60. Our Smart Value Score of 37/100 indicates the stock is weak. TTM revenue stands at $-30.00M.
Frequently asked questions
What is Omeros Corporation's stock price?
Omeros Corporation (OMER) trades at $14.60.
Is Omeros Corporation overvalued?
Smart Value Score 37/100 (Grade D, Sell).
What is the price target of Omeros Corporation (OMER)?
The analyst target price is $38.00, representing +160.3% upside from the current price of $14.60.
What is Omeros Corporation's revenue?
TTM revenue is $-30.00M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.43x
ROE-576.00%
Beta2.53
50D MA$11.67
200D MA$8.62
Shares out0.07B
Float0.07B
Short ratio—
Avg volume1.1M
Performance
1 week+0.45%
1 month+36.94%
3 months+17.35%
YTD-21.22%
1 year—
3 years—
5 years—